chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccinated with Pfizer covid vaccine with second dose Feb 15. She was now diagnosed with covid on August 20; Vaccinated with Pfizer covid vaccine with second dose Feb 15. She was now diagnosed with covid on August 20; This is a spontaneous report from a contactable consumer. This report was received via a sales representative. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 15Feb2021 (Batch/Lot number was not reported) as dose 2, single, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was vaccinated with Pfizer covid vaccine with second dose on Feb 15 and was diagnosed with covid on 20Aug2021. Event took place after use of product. The outcome of events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Got second dose COVID-19 vaccine 1/29/2021, and it looked like it was given very high and she immediately had pain and discomfort. 2 hours later she had excruciating pain in her shoulder and had difficulty moving the shoulder. She is taking ibuprofen and it better. She still has pain and has occasionally shooting pains. She can move it normally now however and began taking ibuprofen prn
Neck , ear, facial, leg, throat, mouth, numbness along left side of body.  Extreme hot feeling in left ear. Nausea. Brain fog, memory/confusion
The patient called our office this afternoon to report that she has had blisters and a burning sensation on her lips since shortly after receiving the first dose of the COVID-19 Moderna vaccine at our office on 03/29/2021. She said these symptoms started around 3/30/21 and that she has not noticed them inside her mouth but rather on her lips. She met virtually with a prescriber on video chat, and this prescriber prescribed her valcyclovir on 04/02/2021. The patient stated that this medication was unhelpful. She reports that she started taking lysine on 04/04/2021 and that this has been somewhat helpful. She stated that she has not contacted her PCP regarding her symptoms, which I recommended her to do regarding treatment.
I had some itching, too; My arm at the injection site is still tender; Hurts when you touch it; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K201A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it). At the time of the report, PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it) outcome was unknown.
had developed rashes over the past week after receiving the YF-VAX; Initial information received on 25-Aug-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves 2 unknown age and unknown gender patient who experienced had developed rashes over the past week after receiving the YELLOW FEVER VACCINE - [YF-VAX].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect YELLOW FEVER VACCINE, solution for injection (lot number and expiry date not reported) via unknown route in unknown administration site for Immunization  On an unknown date the patient developed rashes over the past week after receiving the yf-vax (rash) (unknown latency).  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (had developed rashes over the past week after receiving the YF-VAX).  At time of reporting, the outcome was Unknown for the event had developed rashes over the past week after receiving the yf-vax.
45 to 60 seconds after injection, patient became pale, diaphoretic and fainted. LOC about 10-15 seconds. Responded to stimuli and had no other problems.
Aching in calves in evening p/inject in lt deltoid; later joint pain, fatigue & malaise; neuro exam numbness of face & general unwell appearance;
Area where varicella (RA-SQ) became very reddened, tender and swollen to the size of a silver dollar.  Parent was going to take child to MD for evaluation.
Information has been received from a registered nurse (R.N.) concerning a 14 year old male patient with no drug reactions and allergies and no pertinent medical history, who on unknown date, was vaccinated with the first and only dose of GARDASIL vaccine (Expiration date 11-NOV-2013) (dose was not reported), intramuscular. Lot number (lot # 12618A) is an invalid lot number for GARDASIL vaccine. There was no concomitant therapy. It was reported that, the patient experienced a tonic-clonic seizure in both arms after being administered the vaccine. The patient sought medical attention the event occurred in the physician's office. At the time of reporting the patient was recovered, in the same day the adverse experience occurred. No specific treatment was given. No laboratories diagnostic studies were done. There is the one of several reports received from the same source. Additional information has been requested.
Patient received first Moderna vaccine on April 28th. Did not complain of any adverse effects.  Patient received second Moderna vaccine on May 26th at approximately 11am. Spoke to son at 11pm that night and reported that she felt fine, her arm felt fine, the only complaint was "mouth feels funky" and she felt dehydrated. Was in typical spirits.  She passed on May 27th. Time of death cannot be confirmed as an autopsy was not completed but the assumption is between 6-9am. This would have been less than 24 hours after she received the second vaccine.
Headache,  nausea/vomiting, chills, anxiousness, symptom onset with in 60 minutes of injection Tx-50mg diphenhydramine PO in clinic Rx-40mg prednisone QD x 5 days
After the Pfizer injection I started to have a nose bleed, I saw ER doctor in place of my work, who examined me and told me that the  room I was in was so dry and that my allergies were getting bad. I am scheduled to have my second dose 01-14-2021.
pt recvd 17NOV92 & pt exp a hypersensitivity react permanent injury to immune system,  disorder in immune system, rheumatoid like condition, inflammatory condition; devel GBS assoc w/partial paralysis, polyneuropathy, numbness, facial weak
mom states child came home from school 1JUN98 rt arm was reddened, puffy & warm to touch w/sl fever;mom called 5JUN98 to observe rt arm redness & fever gone but rt deltoid swollen & puffy;7JUN98 mom states arm still tender but dec swelling;
Herpes Zoster in a vaccinated individual. Painful unilateral rash lasting less than 4 weeks. Not given treatment.
Left upper arm with erythema, warmth, induration, and minimal tenderness between deltoid and just above elbow consuming 25% of the arm's circumferance.
Loss of circulation in left and right hands, fingers and thumbs falling asleep frequently. Very similar to Raynaud's disease symptoms. Started 5 minutes after shot and lasted for two weeks.
Per mom patient developed chickenpox around her mouth and one on her chest 10 days after her ProQuad vaccine.
On Tuesday March 31st morning, vaccine was given by LVN. She told me MMR was given in right arm, assuming Varicella is given in left arm. Left arm started to become sore on Wednesday April 1st. Notice a rash, sore, burning, itchy. Took picture on Thursday, informed PCP. Took pictures again today 04/03/20 and notice rash gotten bigger, still sore, burning and itchy.
1-20 minute bouts where tics appear "seizure-like," repetitive; many persistent involuntary tics including coprolalia and violent motor tics; had one minor chronic tic before vaccination/many persistent involuntary tics including coprolalia and violent motor tics/Noticed increase in severity and frequency; many persistent involuntary tics including coprolalia and violent motor tics; Tics often include hitting oneself and banging head against things/violent; significant distress; persistent headache; chronic fatigue/sleepiness; lightheadedness; decrease in appetite; feeling of pressure in certain locations inside the head; intermittent earaches in both ears; persistent feeling of brain being "on fire," and "like a parasite has invaded the brain."; chronic fatigue/sleepiness; This is a spontaneous report from a contactable consumer (patient). A 17-year-old female non-pregnant patient received bnt162b2  (PFIZER BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration, administered in Arm Right on 26Mar2021 as first single dose and on 16Apr2021 as second single dose (Batch/Lot number was not reported) for covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered: Other. Medical history included asthma, allergy to nuts, penicillin and ongoing chronic tic. No other vaccines within 4 weeks prior to the COVID vaccine. No covid prior vaccination. Concomitant medications included duloxetine; atomoxetine; hydroxyzine; loratadine. The patient previously took amoxicillin and experienced allergies. The patient experienced neurological symptoms included many persistent involuntary tics including coprolalia and violent motor tics. Smaller tics can be suppressed for minimal amounts of time before uncontrolled, violent/loud tics occur in rapid succession. Tics often include hitting oneself and banging head against things. The patient had one minor chronic tic before vaccination. Initial onset occurred nine days after vaccination from 04Apr2021. Noticed increase in severity and frequency approximately nine days after second dose of Pfizer vaccine. Symptoms cause significant distress. Additional symptoms included: persistent headache (from date of first vaccine to present); chronic fatigue/sleepiness; light-headedness; decrease in appetite; feeling of pressure in certain locations inside the head not related to the skull or skin; intermittent earaches in both ears; persistent feeling of brain being "on fire" and "like a parasite had invaded the brain, start date was 26Mar2021; and "1- 20 minute bouts where tics appear "seizure-like," repetitive, violent, and controlling".  The patient underwent lab tests and procedures which included Spit test: negative (other) on 26Mar2021 and Apr2021, Covid test: negative on 26Mar2021 and on Apr2021. The events resulted in: Doctor or other healthcare professional office/clinic visit. No treatment received; the patient was not recovered.  Information on lot/batch number has been request.
Information has been received from a physician concerning a 54 year old female patient with high blood pressure, high cholesterol, lupus, diabetes, low thyroid activity, allergy to adhesive bandage, iodinated contrast dye and avocado and with a drug allergy to COMPAZINE who on 18-MAY-2012, was vaccinated with a dose of ZOSTAVAX (Merck) (lot number: 672867/0241AE). Concomitant therapy included diphtheria toxoid (+)( pertussis acellular vaccine (unspecified) (+) tetanus toxoid, GLUMETZA, BYSTOLIC, MAXZIDE, levothyroxine Na, CRESTOR, cholecalciferol, ALLEGRA and multivitamins. It was reported that, on 05-JUN-2012 a patient developed chickenpox-like blisters on her body. She had a clear painful blister on her genital area. She also had a clear painful blister on her right thumb and a clear blister on her right pharynx. The patient developed a low grade fever which lasted until 10-JUN-2012. The patient sought medical attention via calling physician. No lab diagnostic studies were performed. There was no treatment given for AE. By 11-JUN-2012 fever had resolved and blisters were gone. Follow up information has been received from a physician refers to a 54 years old female patient with, hypertension, dyslipidemia, II diabetes and hypothyroidism with none illness at the time of vaccination. The patient was vaccinated with a dose of ZOSTAVAX (dose, route not reported), (lot # 672867/0241AE) on 18-MAY-2012. It was reported that on 05-JUN-2012 the patient reported a clear painful blister developed in the genital area. It was very important. She then developed a similar blister on the pad of her right thumb, very painful. On 08-JUN-2012 she developed a low grade fever, diffuse body aches, malaise, sore throat. She noted a sore blister on the throat, painful. It was reported that fever resolved on 10-JUN-2012 and blister on 19-JUN-2012 (generally patient was resolved from adverse event between 06 and 19 of June 2012). Additional information is not expected.
injection arm  pain; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (injection arm  pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.    Co-suspect product included non-company product ALBUTEROL [SALBUTAMOL] inhaler for an unknown indication.    No medical history was provided by the reporter.  Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) and METFORMIN for an unknown indication.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started ALBUTEROL [SALBUTAMOL] (unknown route) at an unspecified dose. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (injection arm  pain). The patient was treated with MONTELUKAST SODIUM (SINGULAIR) at an unspecified dose and frequency. On 12-Apr-2021, VACCINATION SITE PAIN (injection arm  pain) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include oral birth control.   This case was linked to MOD-2021-118363 (Patient Link).
Large local reaction of right leg with significant swelling, redness, itching, fever and lumpy.
7 month old patient received a dose of Kinrix; received a dose of Kinrix instead of Pediarix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-month-old male patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 3rd March 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 19th November 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 19th November 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received Kinrix in left thigh. The practice administrator reported a 7 month old patient received a dose of Kinrix instead of Pediarix, which led to  inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This case was linked with case US2022006656, reported by same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022006656:same reporter
several pts recvd 1 dose of Engerix-B & 6AUG92 had pain on injection; resolved;
sleeping a lot; weak; tired; sore and achy muscles; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping a lot), ASTHENIA (weak), FATIGUE (tired) and MYALGIA (sore and achy muscles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced SOMNOLENCE (sleeping a lot), ASTHENIA (weak), FATIGUE (tired) and MYALGIA (sore and achy muscles). At the time of the report, SOMNOLENCE (sleeping a lot), ASTHENIA (weak), FATIGUE (tired) and MYALGIA (sore and achy muscles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Flu vaccine given 2/8/16 about 10 AM, about 6 PM - she developed dizziness, difficulty of walking, weakness of both lower extremities. Refer to ER.
Tingling tongue, progressive chest redness. ED transfer with IV solumedrol & Benadryl administered
Developed fever of 101.9 degrees, shivering, very bad headache, stomachache, vomiting, nausea.  The fever had gone down with 20 hours, but hadache and nausea remained for 48 hours.   I had a similar reaction to dose one of the Shingrex vaccine.
"hot flashes" in the middle of the night. She also mentioned that the same thing happened last night.; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unknown route of administration on 09Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient said she received the 1st dose of the bnt162b2 last Saturday. However, she said that after receiving the 1st dose of the vaccine, she started to experience "hot flashes" in the middle of the night. She also mentioned that the same thing happened last night. Patient wanted to know if this was normal. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
A non-serious spontaneous report of given expired FLUMIST was received from a health professional concerning a four-year-old female. Neither the patient's medical history nor the concomitant medications were reported. The product expired on 05-Feb-2012. On 09-Feb-2012, the patient received expired product. There was no adverse event associated with this medication error, therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age.
Systemic: Dizziness / Lightheadness-Mild, Additional Details: Pt experienced mild lightheadness after vaccine, after 5 minutes of drinking water patient felt fine.
No reactions after the first 2 Moderna vaccines taken in March and April 2021.  But 8 days after the Moderna Booster shot (December 2021), I started getting very itchy skin and hives all over the body. I have never had hives or any allergies before ever in my life before.  4 weeks after the shot, I have joint pain and heart burns also. Zyrtec helps with hives (my primary physician's recommendation). Hives come back when I stop Zyrtec
just administered the diluent ( DTAP-IPV) component of the vaccine and wanted to know if the ACT-HIB portion can be administered to complete the dose with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from healthcare professional.  This case involves a 4 months old female patient who was administered with the diluent (DTAP-IPV) component of the vaccine and nurse wanted to know if the ACT-HIB portion can be administered to complete the dose with no reported adverse event while receiving vaccine Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Mrc5)/Hib(Prp/T) Vaccine [Pentacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccinations included Pneumococcal Vaccine Conj 7v (Crm197) (Prevnar) (lot: UJ668AA and Expiry date 13-May-2023) and Rotavirus Vaccine Live Reassort Oral 5v (Rotateq) (lot: UJ668AA and Expiry date 13-May-2023) for Immunisation.  On 06-May-2022, the patient received 0.5 ml 2nd dose of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Mrc5)/Hib(Prp/T) Vaccine [Pentacel] (lot U7256AB and expiry date 13-may-2023) (formulation: unknown) via intramuscular route in the right vastus lateralis for immunization.  On 06-May-2022 the patient developed a non-serious event "just administered the diluent (DTAP-IPV) component of the vaccine and wanted to know if the ACT-HIB portion can be administered to complete the dose with no reported adverse event" (Incorrect dose administered) same day following the administration of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Mrc5)/Hib(Prp/T) Vaccine [Pentacel].  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient reported that she felt "dizzy." This had never happened to her before. She had breakfast this morning. She was on no medications and reported no allergies. Orthostatic BPs were as follows: Lying-95/50, Sitting-103/71, Standing-101/69. She remained alert and oriented x 3. She was given water and juice. Able to ambulate without incident before discharge.
Jaw became sore 1/9/21 , went to ER on 1/11/21 after continued pain diagnosed with Bells Palsy.  Given Medications : Acyclovir 800mg 5 times daily for 7 days, 60 mg prednisone with taper 10 days, Eye patch and Eye drops.
Red/black bruise formation w/huge lump. Lasted for 1 mth &  appeared next day after shot. Soreness for 3 wks, a 3  On a scale of 1-10. Took 800mg MOTRIN. 2x2cm. lump after 1 month.